Together, these results suggest that in addition to the classic vascular signaling pathway underlying the associations between VEGF family members and AD, there may also be immune (e.g., microglial FLT1) and neuronal (e.g., neuronal VEGFB) signaling cascades that contribute to AD pathogenesis. This evidence concerns the gene FLT1 and Alzheimer disease.